EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway

TianYi Chen, YeLing Ruan, Lin Ji, JingWei Cai, Meng Tong, YangTao Xue, Hu Zhao, XiuJun Cai, JunJie Xu

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.216709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von TianYi Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Laparoscopic Technology of Zhejiang Province, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School …. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Bile Duct Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients diagnosed with lymph node (LN) metastatic liver cancer face an exceedingly grim prognosis. In-depth analysis of LN metastatic patients' characteristics and tumor cells' interactions with human lymphatic endothelial cells (HLECs), can provide important biological and therapeutic insights. Here we identify at the single-cell level that S100A6 expression differs between primary tumor and their LN metastasis. Of particular significance, we uncovered the disparity in S100A6 expression between tumors and normal tissues is greater in intrahepatic cholangiocarcinoma (ICC) patients, frequently accompanied by LN metastases, than that in hepatocellular carcinoma (HCC), with rare occurrence of LN metastasis. Furthermore, in the infrequent instances of LN metastasis in HCC, heightened S100A6 expression was observed, suggesting a critical role of S100A6 in the process of LN metastasis. Subsequent experiments further uncovered that S100A6 secreted from tumor cells promotes lymphangiogenesis by upregulating the expression and secretion of vascular endothelial growth factor-D (VEGF-D) in HLECs through the RAGE/NF-kB/VEGF-D pathway while overexpression of S100A6 in tumor cells also augmented their migration and invasion. Taken together, these data reveal the dual effects of S100A6 in promoting LN metastasis in liver cancer, thus highlighting its potential as a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularBile Duct NeoplasmsHumansVascular Endothelial Growth Factor DLymphatic MetastasisNF-kappa BEndothelial CellsLymphangiogenesisBile Ducts, IntrahepaticS100 Calcium Binding Protein A6Cell Cycle Proteins

Stichwörter der Autor:innen

Liver cancerLymph node metastasisLymphangiogenesisS100A6

Substanzen

Vascular Endothelial Growth Factor DNF-kappa BS100A6 protein, humanS100 Calcium Binding Protein A6Cell Cycle Proteins

Autor:innen und Institutionen

  • Key Laboratory of Laparoscopic Technology of Zhejiang Province, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang Minimal Invasive Diagnosis and…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, T., Ruan, Y., Ji, L., Cai, J., Tong, M., Xue, Y., Zhao, H., Cai, X., & Xu, J. (2024). S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216709

Vancouver

Chen T, Ruan Y, Ji L, Cai J, Tong M, Xue Y, et al. S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216709

BibTeX
@article{Chen2024,
  author = {Chen, TianYi and Ruan, YeLing and Ji, Lin and Cai, JingWei and Tong, Meng and Xue, YangTao and Zhao, Hu and Cai, XiuJun and Xu, JunJie},
  title = {S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.216709}
}
Kostenlos starten →